Targeting FGF1-FGFR2 via RORγ Halts Cholangiocarcinoma
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
In a compelling advancement for liver cancer therapeutics, researchers have unveiled a novel molecular axis involving Fibroblast Growth Factor 1 ...
In a groundbreaking advance in cancer biology, new research illuminates the pivotal role of a circular RNA molecule, CircPPFIA2, in ...
In a groundbreaking study published in the Journal of Translational Medicine, researchers have unveiled the potential of Ginsenoside Rh2 as ...
In a groundbreaking study published in the prestigious journal Nature on November 5, 2025, researchers at NYU Langone Health have ...
In a groundbreaking study poised to reshape therapeutic strategies against certain lymphomas, researchers have unveiled an unexpected mechanism by which ...
In a remarkable advancement against one of the most formidable adversaries in the realm of oncology, researchers have unveiled a ...
In a groundbreaking study published in Nature Metabolism, researchers have uncovered a crucial biochemical pathway that determines the vulnerability of ...
In the relentless pursuit of advanced cancer therapeutics, antibody–drug conjugates (ADCs) have carved a significant niche due to their ability ...
In a groundbreaking study poised to redefine therapeutic strategies for colorectal cancer, researchers have identified a novel molecular axis that ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine